The reduction of TGF-β, which reduced CXCR4 receptor expressions on the tumour cell surfaces and weakened the intracellular PI3K/AKT pathway activation, further impeded tumour development and metastasis (Figure 11). This evidence concerns the gene TGFB1 and neoplasm.